Skip to main content
Fig. 4 | The Journal of Headache and Pain

Fig. 4

From: Randomized, double-blind, crossover study comparing DFN-11 injection (3 mg subcutaneous sumatriptan) with 6 mg subcutaneous sumatriptan for the treatment of rapidly-escalating attacks of episodic migraine

Fig. 4

Pain intensity at predose, 30, 60, 90, and 120 min postdosea,b,c. Legend: SC, subcutaneous. a1 subject randomized to 6 mg only treated 1 attack. bRepeated Measures ANOVA revealed an insignificant group and time interaction: F(2.43, 85.02)  =  .61, P  =  .78. cA significant main effect of time was found for pain intensity scores: F(2.43, 85.02)  =  .61, P  <  .001

Back to article page

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us